Navigation Links
PNAS Publishes Preclinical Results of EntreMed's 2ME2 for Multiple Sclerosis
Date:12/4/2012

ROCKVILLE, Md., Dec. 4, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that preclinical results for its compound 2-methoxyestradiol (2ME2) were published on line in this week's Early Edition of Proceedings of the National Academy of Sciences (PNAS).  The study was conducted at The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital and was led by Tak W. Mak, Ph.D. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

Tak W. Mak, Ph.D., Director, The Campbell Family Cancer Research Institute, commented on the study, "Multiple sclerosis (MS) is among the most common autoimmune disorders in the northern hemisphere.  There exists significant unmet medical need for safe and effective drugs to treat MS.  In this study, we demonstrated that 2ME2, an endogenous metabolite of estradiol, significantly inhibits lymphocyte activation and proliferation and dramatically suppresses development of experimental MS.  Our analysis of cellular signaling pathways further reveals that 2ME2 exerts a potent inhibition of Nuclear Factor of Activated T cells (NFAT).  By extension, the study provides for the first time a molecular rational for the use of 2ME2 as a tolerable oral immunomodulatory agent for autoimmune disorders such as MS.  Other studies have shown that in humans, plasma levels of 2ME2 may increase dramatically during the last months of pregnancy, which intriguingly appears to correlate temporally with the remission of clinical symptoms reported in some pregnant MS and rheumatoid arthritis (RA) patients.  We believe that 2ME2 may offer a safe and effective treatment for such autoimmune disorders."

Ken Ren, Ph.D
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
2. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
3. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
4. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
5. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
8. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... AUSTIN, Texas , April 27, 2015 ... solutions company focused on gynecologic disease, announced ... financial results after the market close on ... investor conference call and webcast at 4:30pm ... 2015 at 4:30pm Eastern/1:30pm Pacific Domestic: , ...
(Date:4/27/2015)... Bioscience today announced Bioyong Technology as the fifth certified service ... China . "The Chinese genetics field is ... meaningful innovations that are improving human health both in ... world. We are proud to support the medical and scientific ... Peter Dansky , Agena Bioscience,s CEO. "Chinese researchers ...
(Date:4/27/2015)... , April 27, 2015 ... completed filing of a Pre-Marketing Notification Application (510k) with ... BRH-A2 Wound Management System. BRH Medical expects feedback from ... the US market with BRH-A2 following FDA pre-market clearance. ... Motti Oderberg , CEO for BRH Medical, ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
(Date:4/27/2015)... Ticket Down is a reputable source of ... his upcoming concert on Sunday, June 21st. , Paul McCartney, ... North American fans again in 2015 when he goes out ... tour. He will be performing in some cities overseas ... this legendary performer for the first time in 5 years. ...
(Date:4/27/2015)... 2015 The Doctors on Liens ... of personal injury attorneys with the best doctors working on ... steady growth throughout their history and that trend continues with ... and his team in the Tujunga / Sunland ... massage therapist, patients can find comprehensive care and detailed documentation ...
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... April 27, 2015 A' Design Award ... project SMRT IMAGE Lumica by Boombang Inc Design Team ... A' Design Award in Scientific Instruments, Medical Devices and ... on SMRT IMAGE Lumica, Boombang Inc Design Team, the ... IMAGE Lumica explained “SMRT Image Lumica is a two-way ...
(Date:4/27/2015)... Telematics Berlin is Europe’s biggest Automotive ... CE players and the government to discuss the opportunities ... car. This year’s panel on connected car security with ... Commission, is an opportunity to hear and contribute towards ... Automotive Security Standard for years to come. , ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3
... one of the largest studies in hormone receptor positive ... , PHILADELPHIA, Dec. 11 New ... (lapatinib) plus Femara(R) (letrozole) versus letrozole alone as ... metastatic breast cancer. In the study, women diagnosed with ...
... BOSTON, Dec. 11 The American Federation for,Medical Research ... Tom Daschle,s appointment to the post of Health and ... top,administration official to overhaul the nation,s health care system. ... result of its work since 1940, the AFMR believes ...
... by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: , ... , , It is good ... Future survey released today finds that smoking rates among 8th, ... recorded in this survey for all three grades. However, ...
... released the following statement today on President-elect Obama,s nomination of ... and Human Services and naming him the Director of a ... , "Tom Daschle,s nomination as Secretary of ... the new White House Office of Health Reform is great ...
... among teens is slowing, survey finds , , THURSDAY, Dec. 11 ... among teens, the abuse of painkillers such as Vicodin and ... decline in the use of drugs such as marijuana has ... National Institute on Drug Abuse says in its report, ...
... Midwest Flooding, Indiana Tornadoes , , ... top five disasters of 2008, based on the number of people ... Gustav, Hurricane Ike, the flooding in the Midwest, and the tornadoes ... Weather played a disastrous part in many people,s lives in ...
Cached Medicine News:Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 2Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 3Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 4Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 5Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 6Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 7Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 2Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 3Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 4Health News:New Survey Shows Continued Progress in Reducing Youth Smoking; Congress, States Can Accelerate Declines by Implementing Proven Solutions 2Health News:New Survey Shows Continued Progress in Reducing Youth Smoking; Congress, States Can Accelerate Declines by Implementing Proven Solutions 3Health News:New Survey Shows Continued Progress in Reducing Youth Smoking; Congress, States Can Accelerate Declines by Implementing Proven Solutions 4Health News:10% of U.S. High School Seniors Use Vicodin 2Health News:10% of U.S. High School Seniors Use Vicodin 3Health News:Red Cross Announces Top Five Disaster Responses of 2008 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: